Internal Medicine, Endocrinology, Diabetes, & Metabolism · Odessa, TX
NPI
1740414630
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
701 W 5th St
Odessa, TX, 79763
Phone (432) 335-5250
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
1,403 services
Medicare patients, 2024
237
Average age 73
Drug cost, 2024
$2.8M
4,534 prescriptions
Company payments, 2025
$57K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Vanderheiden was code 99214 (office e&m - established), 391 times for 205 patients. In total Anna Vanderheiden billed 1,403 services in 28 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 391 | 205 | $83.25 | $33K |
| 82962 Clinical Chemistry | Office | 281 | 121 | $3.10 | $870 |
| 83036 Blood Count | Office | 265 | 120 | $9.45 | $2,505 |
| 95251 Test - Miscellaneous | Office | 237 | 85 | $23.49 | $5,568 |
| 99215 Office E&M - Established | Office | 42 | 34 | $125.55 | $5,273 |
| 99212 Office E&M - Established | Office | 41 | 27 | $38.83 | $1,592 |
| 99213 Office E&M - Established | Office | 31 | 28 | $61.02 | $1,892 |
| 82043 Clinical Chemistry | Office | 24 | 22 | $5.66 | $136 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $31.03 | $465 |
| 90662 Vaccine Product | Office | 12 | 12 | $75.00 | $900 |
By year: 2022 $55K for 1,393 services; 2023 $53K for 1,243 services; 2024 $56K for 1,403 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 281 | 121 | $3.10 | $870 |
| 83036 Blood Count | 265 | 120 | $9.45 | $2,505 |
| 82043 Clinical Chemistry | 24 | 22 | $5.66 | $136 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Vanderheiden prescribed most often to Medicare patients was Levothyroxine Sodium, with 473 prescriptions and refills. In total Anna Vanderheiden wrote 4,534 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 473 | 1,298 | 124 | $5,411 |
| Ozempic Semaglutide | 381 | 638 | 81 | $589K |
| Mounjaro Tirzepatide | 342 | 429 | 58 | $447K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 254 | 487 | 52 | $300K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 144 | 338 | 35 | $193K |
| Jardiance Empagliflozin | 107 | 232 | 26 | $129K |
| Synthroid Levothyroxine Sodium | 102 | 238 | 27 | $7,358 |
| Gabapentin Generic | 101 | 206 | 23 | $2,151 |
| Hydrocortisone Generic | 92 | 231 | 21 | $4,456 |
| Tresiba Flextouch U-200 Insulin Degludec | 90 | 196 | 23 | $123K |
| Alendronate Sodium Generic | 89 | 219 | 29 | $930 |
| Metformin Hcl Er Metformin Hcl | 86 | 209 | 25 | $941 |
| Amlodipine Besylate Generic | 81 | 238 | 23 | $754 |
| Atorvastatin Calcium Generic | 76 | 228 | 23 | $800 |
| Tresiba Flextouch U-100 Insulin Degludec | 72 | 214 | 31 | $56K |
Brand drugs: 2,270 claims; generic drugs: 1,759 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Vanderheiden $57K ($57K in general payments such as food, travel and fees) from 24 companies. The largest payer was Novo Nordisk Inc with $36K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 39 | $36K |
| Sanofi-Aventis U.S. LLC SNY | 8 | $11K |
| Dexcom, Inc. DXCM | 9 | $8,600 |
| Insulet Corporation PODD | 10 | $456 |
| Amgen Inc. AMGN | 12 | $293 |
| Averitas Pharma Inc. | 3 | $206 |
| Sequel Med Tech, LLC | 3 | $99.92 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $95.04 |
| Corcept Therapeutics CORT | 4 | $87.67 |
| Beta Bionics, Inc. BBNX | 2 | $59.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.